跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
拜唐苹 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Acarbose Tablets
Approved
化学药品
Acarbose Tablets
Bayer Vital GmbH
🇨🇳 National Medical Products Administration
Approval Date
Sep 17, 2020
Approval ID
888YYbuUgQA
Company
Bayer Vital GmbH
Type
化学药品
Approval Details
Approval Id
888YYbuUgQA
Approval Number
国药准字HJ20130906
Generic Name
阿卡波糖片
Generic Name En
Acarbose Tablets
Trade Name
拜唐苹
Brand Name
拜唐苹
Drug Type
化学药品
Dosage Form
片剂
Strength
50mg
Reg Date
2020-09-17
Expired Date
2025-09-16
Company Name
Bayer Vital GmbH
Production Company Name
BAYER AG
Company Detail Path
/organization/bayer-vital-gmbh
Production Company Detail Path
/organization/bayer-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 17, 2020
Approval ID
888YYbuUgQA
Type
化学药品
Back to NMPA Approvals